{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T21:26:49Z","timestamp":1795037209824,"version":"4.10.2"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T00:00:00Z","timestamp":1539734400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T00:00:00Z","timestamp":1539734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["20790625, 22790829, 16K09676"],"award-info":[{"award-number":["20790625, 22790829, 16K09676"]}]},{"name":"JSPS KAKENHI","award":["18K07536"],"award-info":[{"award-number":["18K07536"]}]},{"name":"JSPS KAKENHI","award":["16K09700"],"award-info":[{"award-number":["16K09700"]}]},{"name":"JSPS KAKENHI","award":["16K09678"],"award-info":[{"award-number":["16K09678"]}]},{"name":"JSPS KAKENHI","award":["18H04043"],"award-info":[{"award-number":["18H04043"]}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"crossref","award":["17km0405206h0002"],"award-info":[{"award-number":["17km0405206h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40478-018-0617-y","type":"journal-article","created":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T08:50:00Z","timestamp":1539766200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Isolated nigral degeneration without pathological protein aggregation in autopsied brains with LRRK2 p.R1441H homozygous and heterozygous mutations"],"prefix":"10.1186","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3100-2370","authenticated-orcid":false,"given":"Masashi","family":"Takanashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Funayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyo","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Tsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenya","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,17]]},"reference":[{"issue":"14","key":"617_CR1","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/mds.25647","volume":"28","author":"Roy N. Alcalay","year":"2013","unstructured":"Alcalay RN, Mirelman A, Saunders-Pullman R, Tang MX, Mejia Santana H, Raymond D, Roos E, Orbe-Reilly M, Gurevich T, Bar Shira A et al (2013, 1966) Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations. Mov Disord 28:\u20131971. \n                    https:\/\/doi.org\/10.1002\/mds.25647","journal-title":"Movement Disorders"},{"key":"617_CR2","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114\u20132120. \n                    https:\/\/doi.org\/10.1093\/bioinformatics\/btu170","journal-title":"Bioinformatics"},{"key":"617_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"617_CR4","doi-asserted-by":"publisher","first-page":"15313","DOI":"10.1074\/jbc.M213128200","volume":"278","author":"S Chandra","year":"2003","unstructured":"Chandra S, Chen X, Rizo J, Jahn R, Sudhof TC (2003) A broken alpha -helix in folded alpha -Synuclein. J Biol Chem 278:15313\u201315318. \n                    https:\/\/doi.org\/10.1074\/jbc.M213128200","journal-title":"J Biol Chem"},{"key":"617_CR5","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ajpath.2012.10.027","volume":"182","author":"SJ Cherra 3rd","year":"2013","unstructured":"Cherra SJ 3rd, Steer E, Gusdon AM, Kiselyov K, Chu CT (2013) Mutant LRRK2 elicits calcium imbalance and depletion of dendritic mitochondria in neurons. Am J Pathol 182:474\u2013484. \n                    https:\/\/doi.org\/10.1016\/j.ajpath.2012.10.027","journal-title":"Am J Pathol"},{"key":"617_CR6","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","volume":"128","author":"JF Crary","year":"2014","unstructured":"Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH et al (2014) Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 128:755\u2013766. \n                    https:\/\/doi.org\/10.1007\/s00401-014-1349-0","journal-title":"Acta Neuropathol"},{"key":"617_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.arr.2017.12.007","volume":"42","author":"H Deng","year":"2018","unstructured":"Deng H, Wang P, Jankovic J (2018) The genetics of Parkinson disease. Ageing Res Rev 42:72\u201385. \n                    https:\/\/doi.org\/10.1016\/j.arr.2017.12.007","journal-title":"Ageing Res Rev"},{"key":"617_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10048-006-0041-5","volume":"7","author":"A Di Fonzo","year":"2006","unstructured":"Di Fonzo A, Wu-Chou YH, Lu CS, van Doeselaar M, Simons EJ, Rohe CF, Chang HC, Chen RS, Weng YH, Vanacore N et al (2006) A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan. Neurogenetics 7:133\u2013138. \n                    https:\/\/doi.org\/10.1007\/s10048-006-0041-5","journal-title":"Neurogenetics"},{"issue":"Suppl 1","key":"617_CR9","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.parkreldis.2017.07.033","volume":"46","author":"DW Dickson","year":"2018","unstructured":"Dickson DW (2018) Neuropathology of Parkinson disease. Parkinsonism Relat Disord 46(Suppl 1):S30\u2013S33. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2017.07.033","journal-title":"Parkinsonism Relat Disord"},{"key":"617_CR10","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/mds.25486","volume":"28","author":"KM Doherty","year":"2013","unstructured":"Doherty KM, Hardy J (2013) Parkin disease and the Lewy body conundrum. Mov Disord 28:702\u2013704. \n                    https:\/\/doi.org\/10.1002\/mds.25486","journal-title":"Mov Disord"},{"key":"617_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-1-4614-3573-0_2","volume":"748","author":"A Ferree","year":"2012","unstructured":"Ferree A, Shirihai O (2012) Mitochondrial dynamics: the intersection of form and function. Adv Exp Med Biol 748:13\u201340. \n                    https:\/\/doi.org\/10.1007\/978-1-4614-3573-0_2","journal-title":"Adv Exp Med Biol"},{"key":"617_CR12","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/mds.21525","volume":"22","author":"JJ Ferreira","year":"2007","unstructured":"Ferreira JJ, Guedes LC, Rosa MM, Coelho M, van Doeselaar M, Schweiger D, Di Fonzo A, Oostra BA, Sampaio C, Bonifati V (2007) High prevalence of LRRK2 mutations in familial and sporadic Parkinson\u2019s disease in Portugal. Mov Disord 22:1194\u20131201. \n                    https:\/\/doi.org\/10.1002\/mds.21525","journal-title":"Mov Disord"},{"key":"617_CR13","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/ana.10113","volume":"51","author":"M Funayama","year":"2002","unstructured":"Funayama M, Hasegawa K, Kowa H, Saito M, Tsuji S, Obata F (2002) A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol 51:296\u2013301","journal-title":"Ann Neurol"},{"key":"617_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/WNR.0b013e32801254b6","volume":"18","author":"M Funayama","year":"2007","unstructured":"Funayama M, Li Y, Tomiyama H, Yoshino H, Imamichi Y, Yamamoto M, Murata M, Toda T, Mizuno Y, Hattori N (2007) Leucine-rich repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population. Neuroreport 18:273\u2013275. \n                    https:\/\/doi.org\/10.1097\/WNR.0b013e32801254b6","journal-title":"Neuroreport"},{"key":"617_CR15","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1136\/jnnp.2006.107904","volume":"78","author":"C Gaig","year":"2007","unstructured":"Gaig C, Marti MJ, Ezquerra M, Rey MJ, Cardozo A, Tolosa E (2007) G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies. J Neurol Neurosurg Psychiatry 78:626\u2013628. \n                    https:\/\/doi.org\/10.1136\/jnnp.2006.107904","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"617_CR16","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/mds.27270","volume":"33","author":"Y Gao","year":"2018","unstructured":"Gao Y, Wilson GR, Stephenson SEM, Bozaoglu K, Farrer MJ, Lockhart PJ (2018) The emerging role of Rab GTPases in the pathogenesis of Parkinson's disease. Mov Disord 33:196\u2013207. \n                    https:\/\/doi.org\/10.1002\/mds.27270","journal-title":"Mov Disord"},{"key":"617_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ana.20791","volume":"59","author":"BI Giasson","year":"2006","unstructured":"Giasson BI, Covy JP, Bonini NM, Hurtig HI, Farrer MJ, Trojanowski JQ, Van Deerlin VM (2006) Biochemical and pathological characterization of Lrrk2. Ann Neurol 59:315\u2013322. \n                    https:\/\/doi.org\/10.1002\/ana.20791","journal-title":"Ann Neurol"},{"key":"617_CR18","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","volume":"51","author":"WR Gibb","year":"1988","unstructured":"Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51:745\u2013752","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"617_CR19","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.parkreldis.2008.07.010","volume":"15","author":"K Hasegawa","year":"2009","unstructured":"Hasegawa K, Stoessl AJ, Yokoyama T, Kowa H, Wszolek ZK, Yagishita S (2009) Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes. Parkinsonism Relat Disord 15:300\u2013306. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2008.07.010","journal-title":"Parkinsonism Relat Disord"},{"key":"617_CR20","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1212\/01.wnl.0000304044.22253.03","volume":"70","author":"K Haugarvoll","year":"2008","unstructured":"Haugarvoll K, Rademakers R, Kachergus JM, Nuytemans K, Ross OA, Gibson JM, Tan EK, Gaig C, Tolosa E, Goldwurm S et al (2008) Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology 70:1456\u20131460. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000304044.22253.03","journal-title":"Neurology"},{"key":"617_CR21","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/s1474-4422(08)70117-0","volume":"7","author":"DG Healy","year":"2008","unstructured":"Healy DG, Falchi M, O'Sullivan SS, Bonifati V, Durr A, Bressman S, Brice A, Aasly J, Zabetian CP, Goldwurm S et al (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case-control study. Lancet Neurol 7:583\u2013590. \n                    https:\/\/doi.org\/10.1016\/s1474-4422(08)70117-0","journal-title":"Lancet Neurol"},{"key":"617_CR22","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1093\/hmg\/ddr348","volume":"20","author":"MC Herzig","year":"2011","unstructured":"Herzig MC, Kolly C, Persohn E, Theil D, Schweizer T, Hafner T, Stemmelen C, Troxler TJ, Schmid P, Danner S et al (2011) LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice. Hum Mol Genet 20:4209\u20134223. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddr348","journal-title":"Hum Mol Genet"},{"key":"617_CR23","doi-asserted-by":"publisher","first-page":"936","DOI":"10.4161\/auto.24397","volume":"9","author":"SJ Hindle","year":"2013","unstructured":"Hindle SJ, Elliott CJ (2013) Spread of neuronal degeneration in a dopaminergic, Lrrk-G2019S model of Parkinson disease. Autophagy 9:936\u2013938. \n                    https:\/\/doi.org\/10.4161\/auto.24397","journal-title":"Autophagy"},{"key":"617_CR24","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/s1474-4422(08)70116-9","volume":"7","author":"MM Hulihan","year":"2008","unstructured":"Hulihan MM, Ishihara-Paul L, Kachergus J, Warren L, Amouri R, Elango R, Prinjha RK, Upmanyu R, Kefi M, Zouari M et al (2008) LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study. Lancet Neurol 7:591\u2013594. \n                    https:\/\/doi.org\/10.1016\/s1474-4422(08)70116-9","journal-title":"Lancet Neurol"},{"key":"617_CR25","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1001\/archneur.63.9.1250","volume":"63","author":"L Ishihara","year":"2006","unstructured":"Ishihara L, Warren L, Gibson R, Amouri R, Lesage S, Durr A, Tazir M, Wszolek ZK, Uitti RJ, Nichols WC et al (2006) Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations. Arch Neurol 63:1250\u20131254. \n                    https:\/\/doi.org\/10.1001\/archneur.63.9.1250","journal-title":"Arch Neurol"},{"key":"617_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1042\/BST20160264","volume":"45","author":"MS Islam","year":"2017","unstructured":"Islam MS, Moore DJ (2017) Mechanisms of LRRK2-dependent neurodegeneration: role of enzymatic activity and protein aggregation. Biochem Soc Trans 45:163\u2013172. \n                    https:\/\/doi.org\/10.1042\/BST20160264","journal-title":"Biochem Soc Trans"},{"key":"617_CR27","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R (2009) Fast and accurate short read alignment with burrows-wheeler transform. Bioinformatics 25:1754\u20131760. \n                    https:\/\/doi.org\/10.1093\/bioinformatics\/btp324","journal-title":"Bioinformatics"},{"key":"617_CR28","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1016\/j.bbamcr.2013.07.020","volume":"1833","author":"C Manzoni","year":"2013","unstructured":"Manzoni C, Mamais A, Dihanich S, Abeti R, Soutar MPM, Plun-Favreau H, Giunti P, Tooze SA, Bandopadhyay R, Lewis PA (2013) Inhibition of LRRK2 kinase activity stimulates macroautophagy. Biochim Biophys Acta 1833:2900\u20132910. \n                    https:\/\/doi.org\/10.1016\/j.bbamcr.2013.07.020","journal-title":"Biochim Biophys Acta"},{"key":"617_CR29","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/mds.22677","volume":"24","author":"JF Marti-Masso","year":"2009","unstructured":"Marti-Masso JF, Ruiz-Martinez J, Bolano MJ, Ruiz I, Gorostidi A, Moreno F, Ferrer I, Lopez de Munain A (2009) Neuropathology of Parkinson\u2019s disease with the R1441G mutation in LRRK2. Mov Disord 24:1998\u20132001. \n                    https:\/\/doi.org\/10.1002\/mds.22677","journal-title":"Mov Disord"},{"key":"617_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10048-005-0005-1","volume":"6","author":"IF Mata","year":"2005","unstructured":"Mata IF, Kachergus JM, Taylor JP, Lincoln S, Aasly J, Lynch T, Hulihan MM, Cobb SA, Wu RM, Lu CS et al (2005) Lrrk2 pathogenic substitutions in Parkinson\u2019s disease. Neurogenetics 6:171\u2013177. \n                    https:\/\/doi.org\/10.1007\/s10048-005-0005-1","journal-title":"Neurogenetics"},{"key":"617_CR31","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M et al (2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20:1297\u20131303. \n                    https:\/\/doi.org\/10.1101\/gr.107524.110","journal-title":"Genome Res"},{"key":"617_CR32","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nn.3350","volume":"16","author":"SJ Orenstein","year":"2013","unstructured":"Orenstein SJ, Kuo SH, Tasset I, Arias E, Koga H, Fernandez-Carasa I, Cortes E, Honig LS, Dauer W, Consiglio A et al (2013) Interplay of LRRK2 with chaperone-mediated autophagy. Nat Neurosci 16:394\u2013406. \n                    https:\/\/doi.org\/10.1038\/nn.3350","journal-title":"Nat Neurosci"},{"key":"617_CR33","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","volume":"44","author":"C Paisan-Ruiz","year":"2004","unstructured":"Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der Brug M, Lopez de Munain A, Aparicio S, Gil AM, Khan N et al (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson\u2019s disease. Neuron 44:595\u2013600. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2004.10.023","journal-title":"Neuron"},{"key":"617_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3233\/JPD-130192","volume":"3","author":"C Paisan-Ruiz","year":"2013","unstructured":"Paisan-Ruiz C, Lewis PA, Singleton AB (2013) LRRK2: cause, risk, and mechanism. J Parkinsons Dis 3:85\u2013103. \n                    https:\/\/doi.org\/10.3233\/JPD-130192","journal-title":"J Parkinsons Dis"},{"key":"617_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/embj.201798099","volume":"37","author":"E Purlyte","year":"2018","unstructured":"Purlyte E, Dhekne HS, Sarhan AR, Gomez R, Lis P, Wightman M, Martinez TN, Tonelli F, Pfeffer SR, Alessi DR (2018) Rab29 activation of the Parkinson\u2019s disease-associated LRRK2 kinase. EMBO J 37:1\u201318. \n                    https:\/\/doi.org\/10.15252\/embj.201798099","journal-title":"EMBO J"},{"key":"617_CR36","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1212\/01.wnl.0000240220.33950.0c","volume":"67","author":"A Rajput","year":"2006","unstructured":"Rajput A, Dickson DW, Robinson CA, Ross OA, Dachsel JC, Lincoln SJ, Cobb SA, Rajput ML, Farrer MJ (2006) Parkinsonism, Lrrk2 G2019S, and tau neuropathology. Neurology 67:1506\u20131508. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000240220.33950.0c","journal-title":"Neurology"},{"key":"617_CR37","doi-asserted-by":"publisher","first-page":"e18568","DOI":"10.1371\/journal.pone.0018568","volume":"6","author":"D Ramonet","year":"2011","unstructured":"Ramonet D, Daher JP, Lin BM, Stafa K, Kim J, Banerjee R, Westerlund M, Pletnikova O, Glauser L, Yang L et al (2011) Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2. PLoS One 6:e18568. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0018568","journal-title":"PLoS One"},{"key":"617_CR38","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/ana.20731","volume":"59","author":"OA Ross","year":"2006","unstructured":"Ross OA, Toft M, Whittle AJ, Johnson JL, Papapetropoulos S, Mash DC, Litvan I, Gordon MF, Wszolek ZK, Farrer MJ et al (2006) Lrrk2 and Lewy body disease. Ann Neurol 59:388\u2013393. \n                    https:\/\/doi.org\/10.1002\/ana.20731","journal-title":"Ann Neurol"},{"key":"617_CR39","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1093\/hmg\/ddu138","volume":"23","author":"J Schapansky","year":"2014","unstructured":"Schapansky J, Nardozzi JD, Felizia F, LaVoie MJ (2014) Membrane recruitment of endogenous LRRK2 precedes its potent regulation of autophagy. Hum Mol Genet 23:4201\u20134214. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddu138","journal-title":"Hum Mol Genet"},{"key":"617_CR40","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/mds.27193","volume":"32","author":"SA Schneider","year":"2017","unstructured":"Schneider SA, Alcalay RN (2017) Neuropathology of genetic synucleinopathies with parkinsonism: review of the literature. Mov Disord 32:1504\u20131523. \n                    https:\/\/doi.org\/10.1002\/mds.27193","journal-title":"Mov Disord"},{"key":"617_CR41","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/nn1776","volume":"9","author":"WW Smith","year":"2006","unstructured":"Smith WW, Pei Z, Jiang H, Dawson VL, Dawson TM, Ross CA (2006) Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nat Neurosci 9:1231\u20131233. \n                    https:\/\/doi.org\/10.1038\/nn1776","journal-title":"Nat Neurosci"},{"key":"617_CR42","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1212\/01.wnl.0000239829.33936.73","volume":"67","author":"C Spanaki","year":"2006","unstructured":"Spanaki C, Latsoudis H, Plaitakis A (2006) LRRK2 mutations on Crete: R1441H associated with PD evolving to PSP. Neurology 67:1518\u20131519. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000239829.33936.73","journal-title":"Neurology"},{"key":"617_CR43","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839\u2013840. \n                    https:\/\/doi.org\/10.1038\/42166","journal-title":"Nature"},{"key":"617_CR44","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.molcel.2014.10.022","volume":"56","author":"A Stolz","year":"2014","unstructured":"Stolz A, Dikic I (2014) PINK1-PARKIN interplay: down to ubiquitin phosphorylation. Mol Cell 56:341\u2013342. \n                    https:\/\/doi.org\/10.1016\/j.molcel.2014.10.022","journal-title":"Mol Cell"},{"key":"617_CR45","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1212\/wnl.0000000000002744","volume":"86","author":"M Takanashi","year":"2016","unstructured":"Takanashi M, Li Y, Hattori N (2016) Absence of Lewy pathology associated with PINK1 homozygous mutation. Neurology 86:2212\u20132213. \n                    https:\/\/doi.org\/10.1212\/wnl.0000000000002744","journal-title":"Neurology"},{"key":"617_CR46","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s00439-006-0268-0","volume":"120","author":"EK Tan","year":"2007","unstructured":"Tan EK, Zhao Y, Skipper L, Tan MG, Di Fonzo A, Sun L, Fook-Chong S, Tang S, Chua E, Yuen Y et al (2007) The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence. Hum Genet 120:857\u2013863. \n                    https:\/\/doi.org\/10.1007\/s00439-006-0268-0","journal-title":"Hum Genet"},{"key":"617_CR47","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1750-1326-7-2","volume":"7","author":"Y Tong","year":"2012","unstructured":"Tong Y, Giaime E, Yamaguchi H, Ichimura T, Liu Y, Si H, Cai H, Bonventre JV, Shen J (2012) Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway. Mol Neurodegener 7:2. \n                    https:\/\/doi.org\/10.1186\/1750-1326-7-2","journal-title":"Mol Neurodegener"},{"key":"617_CR48","doi-asserted-by":"publisher","first-page":"14622","DOI":"10.1073\/pnas.0906334106","volume":"106","author":"Y Tong","year":"2009","unstructured":"Tong Y, Pisani A, Martella G, Karouani M, Yamaguchi H, Pothos EN, Shen J (2009) R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice. Proc Natl Acad Sci U S A 106:14622\u201314627. \n                    https:\/\/doi.org\/10.1073\/pnas.0906334106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"617_CR49","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38:e164. \n                    https:\/\/doi.org\/10.1093\/nar\/gkq603","journal-title":"Nucleic Acids Res"},{"key":"617_CR50","doi-asserted-by":"publisher","first-page":"16842","DOI":"10.1073\/pnas.0507360102","volume":"102","author":"AB West","year":"2005","unstructured":"West AB, Moore DJ, Biskup S, Bugayenko A, Smith WW, Ross CA, Dawson VL, Dawson TM (2005) Parkinson\u2019s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci U S A 102:16842\u201316847. \n                    https:\/\/doi.org\/10.1073\/pnas.0507360102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"617_CR51","doi-asserted-by":"publisher","first-page":"e1000902","DOI":"10.1371\/journal.pgen.1000902","volume":"6","author":"Y Xiong","year":"2010","unstructured":"Xiong Y, Coombes CE, Kilaru A, Li X, Gitler AD, Bowers WJ, Dawson VL, Dawson TM, Moore DJ (2010) GTPase activity plays a key role in the pathobiology of LRRK2. PLoS Genet 6:e1000902. \n                    https:\/\/doi.org\/10.1371\/journal.pgen.1000902","journal-title":"PLoS Genet"},{"key":"617_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tox.2014.07.001","volume":"324","author":"SM Yakhine-Diop","year":"2014","unstructured":"Yakhine-Diop SM, Bravo-San Pedro JM, Gomez-Sanchez R, Pizarro-Estrella E, Rodriguez-Arribas M, Climent V, Aiastui A, Lopez de Munain A, Fuentes JM, Gonzalez-Polo RA (2014) G2019S LRRK2 mutant fibroblasts from Parkinson\u2019s disease patients show increased sensitivity to neurotoxin 1-methyl-4-phenylpyridinium dependent of autophagy. Toxicology 324:1\u20139. \n                    https:\/\/doi.org\/10.1016\/j.tox.2014.07.001","journal-title":"Toxicology"},{"key":"617_CR53","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1212\/01.wnl.0000172630.22804.73","volume":"65","author":"CP Zabetian","year":"2005","unstructured":"Zabetian CP, Samii A, Mosley AD, Roberts JW, Leis BC, Yearout D, Raskind WH, Griffith A (2005) A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations. Neurology 65:741\u2013744. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000172630.22804.73","journal-title":"Neurology"},{"key":"617_CR54","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB et al (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44:601\u2013607. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2004.11.005","journal-title":"Neuron"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0617-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-018-0617-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0617-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T15:09:00Z","timestamp":1589555340000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-018-0617-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,17]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["617"],"URL":"https:\/\/doi.org\/10.1186\/s40478-018-0617-y","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,17]]},"assertion":[{"value":"4 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics committee of the Juntendo University School of Medicine, in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants for genetic and clinical analyses gave full written informed consent before participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"105"}}